Ellis Island Medal Highlights America as a Nation of Immigrants

Ellis Island Immigration Museum pic
Ellis Island Immigration Museum
Image: nycgo.com

As chairman of Cambridge Therapeutics, John Klein leads a team focused on manufacturing high-quality, customer-friendly medical devices, including prescription dispensing modalities for a variety of medications. In addition to his endeavors with Cambridge Therapeutics, John Klein is a recipient of the Ellis Island Medal of Honor.

In 1997, the Ellis Island Honors Society selected Mr. Klein and other recipients as prominent individuals who represent the best values of the United States, highlighting the rich mosaic of backgrounds from which the country’s population today derives. The landmark for which the organization is named is a symbol of the contributions immigrants and their descendants have made to American life.

Ellis Island is a small land mass situated in Upper New York Bay between Manhattan and New Jersey. It takes its name from Samuel Ellis, the merchant who was its owner around the time of the American Revolution. Just after the turn of the 19th century, the federal government purchased the island from the state of New York for use as a fort.

The island would become the largest station through which new immigrants had to enter the country. From 1892 to 1924, about 12 million individuals passed through its precincts. After 1924, its part in the immigration story drew to a close, and it was incorporated into the Statue of Liberty National Monument in 1965. Almost a dozen years later, the National Park Service took over the site’s administration. In 1990, its restored structures opened as the Ellis Island Immigration Museum.

HMH Center for Discovery and Innovation Focuses on Future of Medicine

 Hackensack Meridian Health Hospitals pic
Hackensack Meridian Health Hospitals
Image: hackensackmeridianhealth.org

At Cambridge Therapeutics, based in Teaneck, New Jersey, chairman John Klein directs the work of teams dedicated to innovation in medical products and pharmaceutical packaging. In keeping with his professional focus on helping to deliver high-quality medical care, Cambridge Therapeutics founder John Klein additionally serves on the board of trustees of Hackensack Meridian Health Hospitals.

Affiliated with Hackensack University Medical Center, HMH has developed the Center for Discovery and Innovation, which works to take pioneering techniques in biomedicine and harness them as a means of improving outcomes for patients with debilitating or life-threatening diseases, and as a way to prevent major diseases entirely. The center’s founders believed that the technological innovations of the 21st century can and should inform medical treatment more thoroughly for the benefit of patients and communities.

The center makes use of advances in the fields of genetics and genomics, bioengineering, immunology, and cellular and stem-cell biology, particularly in the treatment of cancer. The regenerative medical programs at the center also aim to discover the best ways of restoring tissues or entire organs damaged through injury or disease.

Among the individual units of the center are the Institute for Cancer and Infectious Diseases, and another institute dedicated to exploring best treatments for multiple myeloma.

Dwight-Englewood School Puts Ethics into Core Curriculum

 

Dwight-Englewood School,pic
Dwight-Englewood School,
Image: d-e.org

At Cambridge Therapeutics in Teaneck, New Jersey, Chairman John Klein and his company work to manufacture high-quality, high-adherence medication packaging and other medical products. In addition to his work at Cambridge Therapeutics, John Klein has given extensively of his time to a number of educational and healthcare-focused nonprofit organizations, and has served as a trustee and past president of the Dwight-Englewood School, one of New England’s premier private preparatory academies.

Also known as D-E, the school currently serves close to 1,000 students, offering a comprehensive, co-educational learning experience for preschool to high school students. The school is proud of its diversity, with students coming from more than 80 distinct regions in New York and New Jersey.

Like many of the nation’s elite schools, D-E maintains a strong focus on ethics, a course required for every student in 10th grade. Among the reasons for teaching ethics at this level are the opportunities it offers students to encounter opposing viewpoints, to learn to identify faulty logic and rhetoric, and to be future leaders in an increasingly complex world.

Students in this one-semester class learn to think critically about important philosophical issues through discussion, intense essay-writing, and readings of case studies. Associated electives offered at the advanced level include honors courses on ancient and modern philosophy, as well as bioethics.